A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Location# 076
Ottawa, Ontario, Canada
- Location # 079
Toronto, Ontario, Canada
- Location# 074
Montreal, Quebec, Canada
- Location# 077
Montreal, Quebec, Canada
- Location# 055
Rimouski, Quebec, Canada
- Location# 066
Tel-Aviv, Central District, Israel
- Location# 071
Kfar Saba, Sharon, Israel
- Location# 072
Beersheba, South District, Israel
- Location# 068
Be’er Ya‘aqov, Israel
- Location# 067
Haifa, Israel
- Location# 073
Jerusalem District, Israel
- Location# 070
Tel Aviv, Israel
- Location# 069
Tel Litwinsky, Israel
- Location# 041
Leiden, NL, Netherlands
- Location # 040
Rotterdam, The Netherlands, Netherlands
- Location #065
Dorchester, Dorset, United Kingdom
- Location # 083
London, England, United Kingdom
- Location #061
London, Greater London, United Kingdom
- Location# 054-2
London, Greater London, United Kingdom
- Location# 057
London, Greater London, United Kingdom
- Location# 064
Manchester, Greater Manchester, United Kingdom
- Location# 056
Edinburgh, Scotland, United Kingdom
- Location# 062
Glasgow, Scotland, United Kingdom
- Location# 054
Sutton, Surrey, United Kingdom
- Location# 063
Leeds, West Yorkshire, United Kingdom
- Location #033
Tucson, Arizona, United States
- Location# 042
Alhambra, California, United States
- Location # 043
Bakersfield, California, United States
- Location# 044
Fullerton, California, United States
- Location# 019
La Jolla, California, United States
- Location# 046
Long Beach, California, United States
- Location# 053
Los Angeles, California, United States
- Location# 051
Northridge, California, United States
- Location# 045
Pomona, California, United States
- Location # 048
Santa Barbara, California, United States
- Location # 049
Santa Barbara, California, United States
- Location# 052
Santa Maria, California, United States
- Location #027
Stanford, California, United States
- Location# 003
Newark, Delaware, United States
- Location# 047
Orlando, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 31 Oct 2011
- Completion
- 31 Jan 2012
- Last update posted
- 20 Sept 2011
- Registered enrollment
- 220
- Registry id
- NCT00931840
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.